应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
PLRZ Polyrizon Ltd.
盘前交易 12-19 05:33:03 EST
3.29
+2.24
+213.33%
盘前
2.83
-0.46
-13.98%
05:11 EST
最高
4.80
最低
2.41
成交量
1.37亿
今开
2.48
昨收
1.05
日振幅
227.62%
总市值
1,380万
流通市值
329.00万
总股本
419.44万
成交额
4.49亿
换手率
13,732.38%
流通股本
100.00万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称：
Polyrizon Ltd.
所属市场：
NASDAQ
上市日期：
--
主营业务：
Polyrizon Ltd.于2005年1月在以色列注册成立。该公司是一家处于发展阶段的生物技术公司，专门开发以鼻喷雾剂形式交付的创新医疗器械水凝胶，该水凝胶在鼻腔内形成一层薄薄的基于水凝胶的防护屏障，可以防止病毒和过敏原接触鼻上皮组织。该公司的C&C水凝胶技术由天然存在的构建块的混合物组成，以鼻喷雾剂的形式提供，并可用作“生物面具”，在鼻腔内有一层薄薄的防护屏障。该公司正在进一步开发其专有的C&C水凝胶技术的某些方面，例如生物粘附性和在鼻腔沉积部位的延长保留时间，以用于鼻内给药。该公司将其专注于API鼻腔给药的独立平台技术称为T&T。
发行价格：
--
{"stockData":{"symbol":"PLRZ","market":"US","secType":"STK","nameCN":"Polyrizon Ltd.","latestPrice":3.29,"timestamp":1734555600000,"preClose":1.05,"halted":0,"volume":137323819,"hourTrading":{"tag":"盘前","latestPrice":2.83,"preClose":3.29,"latestTime":"05:11 EST","volume":12634,"amount":34097.8419568,"timestamp":1734603082242},"delay":0,"floatShares":1000000,"shares":4194445,"eps":0,"marketStatus":"盘前交易","marketStatusCode":1,"change":2.24,"latestTime":"12-19 05:33:03 EST","open":2.48,"high":4.8,"low":2.41,"amount":449395836.75870353,"amplitude":2.27619,"askPrice":3,"askSize":131,"bidPrice":2.78,"bidSize":106,"shortable":3,"etf":0,"ttmEps":0,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734618600000},"adr":0,"listingDate":1730174400000,"adjPreClose":3.29,"preHourTrading":{"tag":"盘前","latestPrice":2.83,"preClose":3.29,"latestTime":"05:11 EST","volume":12634,"amount":34097.8419568,"timestamp":1734603082242},"postHourTrading":{"tag":"盘后","latestPrice":2.79,"preClose":3.29,"latestTime":"19:59 EST","volume":429435,"amount":1287643.8262,"timestamp":1734569994545},"volumeRatio":84.495765307066},"requestUrl":"/m/hq/s/PLRZ","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.polyrizon-biotech.com","stockEarnings":[{"period":"1week","weight":2.4552},{"period":"1month","weight":2.29},{"period":"3month","weight":-0.2489},{"period":"ytd","weight":-0.2489}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Polyrizon Ltd.于2005年1月在以色列注册成立。该公司是一家处于发展阶段的生物技术公司，专门开发以鼻喷雾剂形式交付的创新医疗器械水凝胶，该水凝胶在鼻腔内形成一层薄薄的基于水凝胶的防护屏障，可以防止病毒和过敏原接触鼻上皮组织。该公司的C&C水凝胶技术由天然存在的构建块的混合物组成，以鼻喷雾剂的形式提供，并可用作“生物面具”，在鼻腔内有一层薄薄的防护屏障。该公司正在进一步开发其专有的C&C水凝胶技术的某些方面，例如生物粘附性和在鼻腔沉积部位的延长保留时间，以用于鼻内给药。该公司将其专注于API鼻腔给药的独立平台技术称为T&T。","exchange":"NASDAQ","name":"Polyrizon Ltd.","nameEN":"Polyrizon Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Polyrizon Ltd.(PLRZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Polyrizon Ltd.(PLRZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Polyrizon Ltd.,PLRZ,Polyrizon Ltd.股票,Polyrizon Ltd.股票老虎,Polyrizon Ltd.股票老虎国际,Polyrizon Ltd.行情,Polyrizon Ltd.股票行情,Polyrizon Ltd.股价,Polyrizon Ltd.股市,Polyrizon Ltd.股票价格,Polyrizon Ltd.股票交易,Polyrizon Ltd.股票购买,Polyrizon Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Polyrizon Ltd.(PLRZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Polyrizon Ltd.(PLRZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}